-+ 0.00%
-+ 0.00%
-+ 0.00%

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga·04/01/2026 12:09:57
Listen to the news
Scinai Immunotherapeutics (NASDAQ:SCNI) reported quarterly losses of $(3.56) per share. The company reported $1.311 million in sales this quarter. This is a 99.24 percent increase over sales of $658.000 thousand the same period last year.